These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36380383)

  • 21. Antiretroviral drug concentrations in hair are associated with virologic outcomes among young people living with HIV in Tanzania.
    Tabb ZJ; Mmbaga BT; Gandhi M; Louie A; Kuncze K; Okochi H; Shayo AM; Turner EL; Cunningham CK; Dow DE
    AIDS; 2018 Jun; 32(9):1115-1123. PubMed ID: 29438196
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Effect of Real-Time Medication Monitoring-Based Digital Adherence Tools on Adherence to Antiretroviral Therapy and Viral Suppression in People Living With HIV: A Systematic Literature Review and Meta-Analysis.
    Msosa TC; Swai I; Aarnoutse R; Rinke de Wit TF; Ngowi K; Msefula C; Nliwasa M; Boer MS
    J Acquir Immune Defic Syndr; 2024 Aug; 96(5):411-420. PubMed ID: 38985562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring adherence to antiretroviral therapy among adolescents in Southern Uganda: comparing Wisepill to Self-report in predicting viral suppression in a cluster-randomized trial.
    Kizito S; Namuwonge F; Brathwaite R; Neilands TB; Nabunya P; Bahar OS; Damulira C; Mwebembezi A; Mellins C; McKay MM; Ssewamala FM
    J Int AIDS Soc; 2022 Sep; 25(9):e25990. PubMed ID: 36052462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of self-report antiretroviral adherence for predicting HIV viral load among persons who inject drugs in Hai Phong Vietnam: assessing differences by methamphetamine use.
    Feelemyer J; Des Jarlais DC; Nagot N; Huong DT; Oanh KTH; Khue PM; Thi Giang H; Tuyet Thanh NT; Cleland CM; Arasteh K; Caniglia E; Chen Y; Bart G; Moles JP; Vinh VH; Vallo R; Quillet C; Rapoud D; Le SM; Michel L; Laureillard D; Khan MR
    AIDS Care; 2024 Apr; 36(4):553-560. PubMed ID: 37909053
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of self-report adherence measures and their associations with detectable viral load among people living with HIV (PLHIV) in China.
    Da W; Li X; Qiao S; Zhou Y; Shen Z
    PLoS One; 2018; 13(8):e0203032. PubMed ID: 30161177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sub-optimal adherence to combination anti-retroviral therapy and its associated factors according to self-report, clinician-recorded and pharmacy-refill assessment methods among HIV-infected adults in Addis Ababa.
    Mekuria LA; Prins JM; Yalew AW; Sprangers MA; Nieuwkerk PT
    AIDS Care; 2017 Apr; 29(4):428-435. PubMed ID: 27701908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Returning of antiretroviral medication dispensed over a period of 8 months suggests non-adherence despite full adherence according to real time medication monitoring.
    Ngowi KM; Masika L; Lyamuya F; Muro E; Mmbaga BT; Sprangers MAG; Nieuwkerk PT; Aarnoutse RE; Reiss P; Sumari-de Boer IM
    AIDS Res Ther; 2020 Sep; 17(1):57. PubMed ID: 32912282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study.
    O'Halloran Leach E; Lu H; Caballero J; Thomas JE; Spencer EC; Cook RL
    AIDS Res Ther; 2021 Jun; 18(1):36. PubMed ID: 34174904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacy and self-report adherence measures to predict virological outcomes for patients on free antiretroviral therapy in Tamil Nadu, India.
    McMahon JH; Manoharan A; Wanke CA; Mammen S; Jose H; Malini T; Kadavanu T; Jordan MR; Elliott JH; Lewin SR; Mathai D
    AIDS Behav; 2013 Jul; 17(6):2253-9. PubMed ID: 23435750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association between pharmacy medication refill-based adherence rates and cd4 count and viral-load responses: A retrospective analysis in treatment-experienced adults with HIV.
    Townsend ML; Jackson GL; Smith R; Wilson KH
    Clin Ther; 2007 Apr; 29(4):711-6. PubMed ID: 17617294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy.
    O'Connor JL; Gardner EM; Esser S; Mannheimer SB; Lifson AR; Telzak EE; Phillips AN;
    HIV Med; 2016 Feb; 17(2):124-32. PubMed ID: 26186609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence determination using urine-tenofovir point-of-care testing and pharmacy refill records: A cross-sectional study.
    Herbertson EC; Lahiri CD; Olugbake OA; Soremekun RO; Spinelli MA; Gandhi M
    Medicine (Baltimore); 2023 Nov; 102(47):e36321. PubMed ID: 38013290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of Delay to Pharmacy Refill in Assessing Adherence to Antiretroviral Therapy.
    Cruz CCP; Mistro S; Mendes CMC; Schooley RT; Badaró RJDS
    J Pharm Pract; 2020 Apr; 33(2):158-163. PubMed ID: 30122111
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of an Integrated Health System Specialty Pharmacy on HIV Antiretroviral Therapy Adherence, Viral Suppression, and CD4 Count in an Outpatient Infectious Disease Clinic.
    Barnes E; Zhao J; Giumenta A; Johnson M
    J Manag Care Spec Pharm; 2020 Feb; 26(2):95-102. PubMed ID: 32011966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Utility of Pharmacy-Based Adherence Measurement in Predicting Virologic Outcomes in an Adult HIV-Infected Cohort in Jos, North Central Nigeria.
    Abah IO; Ojeh VB; Musa J; Ugoagwu P; Agaba PA; Agbaji O; Okonkwo P
    J Int Assoc Provid AIDS Care; 2016; 15(1):77-83. PubMed ID: 24963086
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Medication Adherence Assessment Tools to Identify Glaucoma Medication Nonadherence.
    Cho J; Niziol LM; Lee PP; Heisler M; Resnicow K; Musch DC; Newman-Casey PA
    Ophthalmol Glaucoma; 2022; 5(2):137-145. PubMed ID: 34358735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High turnaround times and low viral resuppression rates after reinforced adherence counselling following a confirmed virological failure diagnostic algorithm in HIV-infected patients on first-line antiretroviral therapy from Tanzania.
    Kroidl A; Burger T; Urio A; Mugeniwalwo R; Mgaya J; Mlagalila F; Hoelscher M; Däumer M; Salehe O; Sangare A; Lennemann T; Maganga L
    Trop Med Int Health; 2020 May; 25(5):579-589. PubMed ID: 31984634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of non-adherence to antiretroviral therapy among HIV infected patients in northern Tanzania.
    Semvua SK; Orrell C; Mmbaga BT; Semvua HH; Bartlett JA; Boulle AA
    PLoS One; 2017; 12(12):e0189460. PubMed ID: 29252984
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships among neurocognitive status, medication adherence measured by pharmacy refill records, and virologic suppression in HIV-infected persons.
    Andrade AS; Deutsch R; A Celano S; Duarte NA; Marcotte TD; Umlauf A; Atkinson JH; McCutchan JA; Franklin D; Alexander TJ; McArthur JC; Marra C; Grant I; Collier AC
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):282-92. PubMed ID: 23202813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.